An investigator-led trial of Jazz Pharma's cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer - will get underway in the UK next year.
The use of medical cannabis in the UK has moved a step closer, after the home secretary asked for advice following a review that concluded that there is evidence of therapeutic benefit.
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.